EFAD Performance — ProShares MSCI EAFE Dividend Growers ETF
Data updated: 2026-08-14
EFAD returned +3.61% year to date and +4.74% over one year to May 2026. Annualised returns are +8.10% over 3 years and +1.24% over 5 years. The fund trailed its International Large Blend category average: $100 invested three years ago grew to $126, against $161 for the category, and to $105 over one year, against $122. Volatility over the past three years was 13.37% a year. In the 12 months to May 2026 the fund lost a net $9.6M, and assets reached $61.79M.
EFAD Growth of $100
What $100 invested in ProShares MSCI EAFE Dividend Growers ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Large Blend category average over the same months.
| Period | EFAD | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $105 | $122 |
| 3 years (Jun 2023 – May 2026) | $126 | $161 |
| 5 years (Jun 2021 – May 2026) | $106 | $144 |
| Since data start (Sep 2019 – May 2026) | $138 | $194 |
EFAD Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +3.61% |
| 1 year | +4.74% |
| 3 years (annualised) | +8.10% |
| 5 years (annualised) | +1.24% |
EFAD Annual Returns
Calendar-year total returns of ProShares MSCI EAFE Dividend Growers ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +3.61% |
| 2025 | +15.26% |
| 2024 | −1.42% |
| 2023 | +11.96% |
| 2022 | −21.10% |
| 2021 | +7.84% |
| 2020 | +9.29% |
| 2019 (Sep–Dec) | +12.76% |
EFAD Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.0% | +3.8% | −8.7% | +5.3% | +1.8% | — | — | — | — | — | — | — |
| 2025 | +3.5% | +0.2% | +0.1% | +6.7% | +3.0% | +1.9% | −4.3% | +3.2% | +0.7% | −1.2% | +0.9% | +0.2% |
| 2024 | −0.1% | +0.2% | +1.1% | −4.0% | +1.9% | −0.1% | +5.0% | +4.8% | +1.3% | −6.7% | −0.3% | −3.9% |
| 2023 | +5.4% | −3.0% | +3.4% | +3.2% | −4.3% | +0.8% | +3.1% | −2.7% | −4.8% | −4.2% | +8.7% | +6.9% |
| 2022 | −9.5% | −1.4% | −0.1% | −6.7% | −2.0% | −6.3% | +6.0% | −5.4% | −8.5% | +3.1% | +9.1% | +0.2% |
| 2021 | −1.5% | −1.7% | +3.0% | +2.9% | +2.7% | +0.4% | +4.0% | +2.1% | −4.3% | +1.7% | −4.1% | +2.9% |
| 2020 | −0.9% | −8.9% | −12.7% | +8.4% | +4.3% | +3.3% | +1.5% | +5.5% | −0.2% | −4.1% | +12.4% | +3.1% |
| 2019 | — | — | — | — | — | — | — | — | +3.0% | +4.2% | +1.2% | +3.7% |
EFAD Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 13.37%
- 3-year Sharpe ratio: 0.27 (vs 4.5% risk-free rate)
- Best month: +8.72% (Nov 2023)
- Worst month: −8.71% (Mar 2026)
EFAD Fund Flows
Monthly money in and out of ProShares MSCI EAFE Dividend Growers ETF, from SEC Form N-PORT.
- 12-month net flow: −$9.6M
- 12-month gross sales (incl. reinvestments): $1.7M
- Sales ÷ redemptions: 0.15×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $0 | $1.3M | −$1.3M |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $0 | $1.7M | −$1.7M |
| Dec 2025 | $0 | $1.3M | −$1.3M |
| Nov 2025 | $0 | $2.5M | −$2.5M |
| Oct 2025 | $0 | $1.7M | −$1.7M |
| Sep 2025 | $0 | $2.9M | −$2.9M |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $1.7M | $0 | $1.7M |
| Jun 2025 | $0 | $0 | $0 |
EFAD Assets Under Management
Net assets of ProShares MSCI EAFE Dividend Growers ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $61.79M |
| 2026-02-28 | $64.56M |
| 2025-11-30 | $64.58M |
| 2025-08-31 | $71.82M |
| 2025-05-31 | $70.45M |
| 2025-02-28 | $64.15M |
| 2024-11-30 | $71.56M |
| 2024-08-31 | $80.36M |
| 2024-05-31 | $76.32M |
| 2024-02-29 | $86.54M |
| 2023-11-30 | $88.71M |
| 2023-08-31 | $93.25M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.